Delivery Order SPE2DB22D1017-SPE2DB24FF0KU
- Not listed
- This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The $1,584.34 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. The...
- The federal contract award is for the delivery of Carvedilol ER 80 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $26,424.85, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 13, 2024. The contract is not set aside for any specific designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA). The $7,482.60 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The contract has an ultimate completion date of March 27, 2023 and was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The contract, worth $1,098.58, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Carvedilol ER 10 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type, valued at $4,227.55, with an ultimate completion date of January 16, 2024. The contract was awarded on January 12, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Carvedilol ER 20 mg capsules, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $12,061.08 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The order has a completion date of July 12, 2023 and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price of $27,708.46 and an ultimate completion date of September 21, 2023. The award was made without any set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $3,756.61, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price and has an ultimate completion date of March 7, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Carvedilol ER 20 MG capsules. The $13,542.96 firm fixed-price delivery order has an ultimate completion date of February 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF0KUDelivery Order
This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract valued at $7,371.83 with a completion date of December 28, 2023. The contract is a firm fixed price arrangement and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 12/27/23 |